Correlation between irAEs and treatment efficacy of anti-PD-1 single agent in patients with recurrent/metastatic head and neck squamous cell carcinoma: A monocentric real-world observational study

被引：0
|
作者：
Gottardi, Chiara
Anile, Giuseppe
Micheletto, Ilaria
Krengli, Marco
Carobbio, Andrea Luigi Camillo
El Khouzai, Badr
Taboni, Stefano
Pretto, Greta
Guarneri, Valentina
Ghi, Maria Grazia
机构：
[1] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
[2] Veneto Inst Oncol IOV IRCCS, Oncol Unit 2, Padua, Italy
[3] Veneto Inst Oncol IOV IRCCS, Radiotherapy Unit, Padua, Italy
[4] Univ Padua, Dept Neurosci, Sect Otorhinolaryngol Head Neck Surg, Padua, Italy
[5] Veneto Inst Oncol IOV IRCCS, Dept Radiotherapy, Padua, Italy
[6] Univ Padua, Dept Surg Oncol & Gastroenterol, Veneto Inst Oncol IOV IRCCS, Oncol Unit 2, Padua, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6029
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world data of nivolumab efficacy for treatment of recurrent or metastatic head and neck squamous cell carcinoma
    Nosova, M. V.
    Stativko, O.
    Tsareva, E.
    Shangina, I.
    Ibragimova, M.
    Zueva, E.
    Latkin, V.
    Sobolev, M.
    Kuchevskaya, O.
    Arapova, O.
    Sabitov, E.
    Antonova, T.
    Pokataev, I.
    Galkin, V. N.
    ANNALS OF ONCOLOGY, 2024, 35
  • [2] Duvelisib with docetaxel for patients with anti-PD-1 refractory, recurrent, or metastatic head and neck squamous cell carcinoma
    Hanna, Glenn J.
    Oakley, Liam B.
    Shi, Ruichao
    ONeill, Anne
    Shin, Kee-Young
    Sehgal, Kartik
    Dennis, Michael J.
    Jo, Vickie Y.
    Wong, Kristine S.
    Haddad, Robert I.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma
    Hanna, Glenn J.
    Oakley, L. B.
    Shi, R.
    Oneill, A.
    Shin, K. Y.
    Scarfo, N.
    Sehgal, K.
    Dennis, M. J.
    Quinn, N.
    Jo, V. Y.
    Wong, K.
    Shvyrkova, A.
    Kushnarev, V.
    Shanthappa, B. U.
    Tkachuk, A.
    Kryukov, K.
    Sarachakov, A.
    Svekolkin, V.
    Lennerz, J.
    Waters, S.
    Haddad, R. I.
    CLINICAL CANCER RESEARCH, 2025, 31 (04) : 619 - 627
  • [4] Real-world outcomes and costs in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Lafuma, A.
    Cotte, F-E.
    Le Tourneau, C.
    Emery, C.
    Gaudin, A-F.
    Torreton, E.
    Gourmelen, J.
    Bonastre, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [5] Combination of anti-PD-1 inhibitors with radiotherapy for recurrent/metastatic squamous cell carcinoma in the head and neck region
    Tamaskovics, Balint
    Haussmann, Jan
    Neuwahl, Judith
    Jazmati, Danny
    Plettenberg, Christian
    Althaus, Laurenz
    Boelke, Edwin
    Matuschek, Christiane
    Budach, Wilfried
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S166 - S166
  • [6] Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
    Saada-Bouzid, E.
    Defaucheux, C.
    Karabajakian, A.
    Coloma, V. P.
    Servois, V.
    Paoletti, X.
    Even, C.
    Fayette, J.
    Guigay, J.
    Loirat, D.
    Peyrade, F.
    Alt, M.
    Gal, J.
    Le Tourneau, C.
    ANNALS OF ONCOLOGY, 2017, 28 (07) : 1605 - 1611
  • [7] Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study
    Iglesias, Leticia
    Vilchez, Rocio
    Aguin, Santiago
    Garcia, Ramon
    Pena, Carolina
    Carral, Alberto
    Huidobro, Gerardo
    Molina, Aurea
    Gomez, JESuS GARCiA
    Covela, Marta
    Costa, Marinha
    Medina, Ana
    ANTICANCER RESEARCH, 2025, 45 (03) : 1181 - 1191
  • [8] HANNA: Real-world outcomes from an observational study with nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck in Germany.
    Dietz, Andreas
    Welslau, Manfred
    Hahn, Dennis
    Langer, Christine
    Bockmuehl, Ulrike
    Mueller-Huesmann, Harald
    Busch, Chia-Jung
    Riera-Knorrenschild, Jorge
    Buentzel, Jens
    Kubuschok, Boris
    von der Gruen, Jens
    Gauler, Thomas Christoph
    Waldenberger, Daniela
    von der Heyde, Eyck
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and neck patients
    Zandberg, Dan P.
    Zenkin, Serafettin
    Ak, Murat
    Mamindla, Priyadarshini
    Peddagangireddy, Vishal
    Hsieh, Ronan
    Anderson, Jennifer L.
    Delgoffe, Greg M.
    Menk, Ashely
    Skinner, Heath D.
    Duvvuri, Umamaheswar
    Ferris, Robert L.
    Colen, Rivka R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025, 47 (01): : 129 - 138
  • [10] Real-world time on treatment with immuno-oncology therapy in recurrent/metastatic head and neck squamous cell carcinoma
    Ramakrishnan, Karthik
    Liu, Zhiwen
    Baxi, Shrujal
    Chandwani, Sheenu
    Joo, Sam
    Chirovsky, Diana
    FUTURE ONCOLOGY, 2021, 17 (23) : 3037 - 3050
12345